Stay updated on Nivolumab Combo in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Head & Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab Combo in Head & Neck Cancer Clinical Trial page
- Check3 days agoChange DetectedRevision notes show the addition of v3.5.0 and removal of v3.4.3.SummaryDifference0.1%

- Check10 days agoChange DetectedThe revision tag on the page was updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe sponsor and affiliated institution names were updated to the official designation: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. The page now lists Thomas Jefferson University (Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University) and removes the alternate aliases to standardize naming.SummaryDifference0.3%

- Check39 days agoChange DetectedFooter updated to revision v3.4.2 (from v3.4.1); no changes to study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1, a minor metadata change with no impact on study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page shows minor UI and metadata updates, including a 'Show glossary' option and a revision label of v3.4.0, along with capitalization normalization of 'Last Update' QC criteria and 'No FEAR Act data' wording. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Nivolumab Combo in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Head & Neck Cancer Clinical Trial page.